TNF and inflammatory bowel disease: Previous studies have shown that the anti-TNF treatment infliximab is associated with reduced immunogenicity to influenza vaccination.13–16 However, data on responses to influenza vaccination in patients with IBD receiving thiopurine monotherapy, ustekinumab [anti-IL-12/23], vedolizumab, and tofacitinib are scarcer.